JAN 04, 2016 12:29 PM PST

'STING' Pathway Inhibited By Colorectal Cancer Cells

WRITTEN BY: Kara Marker
The stimulator of interferon genes (STING) pathway, discovered in 2008 to promote type 1 interferon production in response to a pathogenic infection, was recently found to also play a role in suppressing colorectal cancer cells (Journal of Molecular Cell Biology). Many populations of abnormally growing tumor cells inhibit STING in order to avoid immune system detection.

Type 1 interferons play a multi-faceted role in activate both the innate and adaptive immune system; interferon-related production of various cells reduces tissue damage during infection and prevents autoimmune activity (Nature Reviews Immunology). From the Sylvester Comprehensive Center at the University of Miami Miller School of Medicine, scientists investigate the role of the STING pathway in controlling cells like type 1 interferons during cases of colorectal cancer. Their study was recently published in Cell Reports.

Almost all cases of colorectal cancers are adenocarnomas that begin growth in glandular cells inside the colon or rectum. Although the death rate from colorectal cancer has been steadily dropping during the past two decades, about 50,000 people died from this cancer in 2015 (American Cancer Society). 
 

Researchers used a technique called “epigenetic hypermethylation” to mute the effect of STING signaling in order to replicate and visualize how colorectal cancer cells grow and evade the immune system. They did this by adding a methyl group to STING-specific DNA to inhibit transcription (Nature).

Without properly functioning STING signaling, DNA-damaged cells went undetected by the body’s immune cells. Inhibition of the STING pathway prevented cytokine production, which resulted in decreased tissue repair and “anti-tumor cytotoxic T cell priming” (Cell). A loss of antigen-presenting cells called dendritic cells also occurs without STING signaling. Dendritic cells are needed to recognize tumor cells circulating in the blood stream.
 


If loss of STING activity leads to unrestrained cancer growth, shouldn’t scientists figure out a way to turn STING activity back on? This is certainly a potential answer for colorectal cancer, but scientists also have to consider the careful balance of STING activity that must be kept. Overstimulation of this pathway has numerous consequences such as autoinflammatory disease and “inflammation driven skin cancer” (Cell).

Source: Cell Reports
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAY 22, 2018
Cancer
MAY 22, 2018
Novel PD-L1/TGF-ß Fusion Protein for HPV-Associated Cancers Enters Phase II Clinical Trial
Novel PD-L1/TGF-ß fusion protein for HPV-associated cancers enters phase II clinical trial. Oncology researchers excited about the potential of this bi-functional protein to combat cancer...
JUN 21, 2018
Immunology
JUN 21, 2018
The Silver Tsunami: An Aging Immune System and Cancer
Why do cases of cancer become more common as we get older? Scientists interested in explaining the so-called “Silver Tsunami” phenomenon look t...
JUN 25, 2018
Immunology
JUN 25, 2018
An Emerging Chronic Food Allergy: Eosinophilic Esophagitis
There’s a new food allergy in town, and it seems that children with existing allergies at an increased risk of developing it. From the Children&rsquo...
JUL 04, 2018
Drug Discovery
JUL 04, 2018
Increased Dose of Drug 'Rifampin' Effective in Eliminating Tuberculosis Bacterium
According to a randomized controlled trial, a TB drug by the name ‘Rifampin’ was seen to effectively kill TB bacteria in sputum cultures when a...
JUL 09, 2018
Immunology
JUL 09, 2018
Protein Complex Determines the Fate of T cells
The protein complex mTORC1 has been shown to integrate metabolic and signaling activity to determine the fate of T cell lineage between alpha beta and gamma delta....
JUL 10, 2018
Health & Medicine
JUL 10, 2018
Towards a Universal Flu Vaccine
Each year, depending on the weather and other factors, flu season shows up and sometimes it’s really bad and other times it’s not as widespread...
Loading Comments...